We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Better DNA Microarray Analysis

By Biotechdaily staff writers
Posted on 03 Jan 2006
A new method that blends experiment and computation makes DNA microarray analysis more sensitive and specific, promising to improve research on diseases.

DNA microarray identifies gene activation in living, complex biologic systems. More...
It monitors the behavior of thousands of genes over time by detecting changes in the expression of as many as 30,000 different genes on one small chip. The technique has been used to study some of the most important biologic systems, including how cells divide and immune responses to disease and infection.

The new procedure is based on a "check-sum” protocol initially developed to ensure that e-mail messages did not become garbled in transmission. In standard Internet protocol, bits of information that begin as one value (0 or 1) may flip to the opposite value as they move from one computer to the next via e-mail. This data loss is checked by counting the number of ones in the message. If this number is odd, then the last bit is set to one; otherwise, it is set to zero. By comparing the last bit on the receiving end, the recipient's computer can tell whether the message was accurately received. If not, the recipient's computer asks the sender's computer to forward the message again.

The new DNA microarray method carries out a similar analysis of the microarray snapshots by checking the sum of a set of DNA microarray data points over time against the summary of the temporal response. If the two sets of results are equal, then what is captured by the microarray time series is real. If the time series results produce a lower value than the microarray summary, the protocol indicates that the researchers have missed a gene's activation somewhere in their time series.

Just as important is whether a DNA microarray summary value exceeds its time sequence value. If that happens, then researchers have likely identified gene activity that should be attributed to changes taking place during an experiment, such as adding a chemical or changing the temperature. This part of the method provides the specificity required to weed out such introduced gene activation from gene activation pathways that form the hallmark of processes such as cancer or immunity.

The new DNA microarray method was developed by Ziv Bar-Joseph, assistant professor of computer science and biologic sciences at Carnegie Mellon University (Pittsburgh, PA, USA), together with collaborators at the Hebrew University (Jerusalem, Israel). Their work was described in the December 2005 issue of Nature Biotechnology.

To prove the effectiveness of their method, Dr. Bar-Joseph studied the human cell division cycle, which plays a major role in cancer. He and his colleagues identified many new human genes that were not previously found to be participants in this system. The new method also overcomes synchronization loss, which occurs as groups of cells become asynchronized in their activities.

"We are very excited about introducing this versatile, powerful method to the research community because it can be used to study a wide range of complex, dynamic systems more comprehensively,” observed Dr. Bar-Joseph. "Such systems under study include stress and drug response, cancer, and embryo development.”




Related Links:
Carnegie Mellon U.

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer cells (red) stick to mesothelial cells (green) and form hybrid spheres that cut into surrounding abdominal tissue (Photo courtesy of Uno et al., 2026)

Abdominal Fluid Testing Can Predict Ovarian Cancer Progression

Ovarian cancer kills more women than any other gynecological cancer, largely because it is usually diagnosed only after it has spread widely within the abdomen. Unlike many other cancers, it does not rely... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.